Skip to content

MIMEDX GROUP, INC.

MDXG · XNAS

CIK 1376339fmd_0Y2RS3GK9641BKHA0TNRG24KT2Manufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Jan 01, 2010 to Sep 30, 2026, 66 periods

Income Statement · Annual · Millions · USD
Line itemFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Total revenues222321359299248242268321349419
Cost of revenue31353643394048556073
Net interest income(0)(0)1(5)(8)(5)(5)(6)––
Gross profit191286323256209202220267289346
Research and development14181611121013131215
Selling, general and administrative173220259198181195209211225266
Operating income146(4)(21)(45)(7)(15)375964
Interest expense0–––––5742
Interest and investment income––––––0035
Other non-operating income (expense)(0)000(0)(0)(0)(0)(1)(1)
Income before taxes145(3)(26)(62)(12)(20)315766
Income tax expense0(20)27(0)(12)00(37)1518
Net income from continuing operations065(30)(26)(49)(12)(20)674249
Net income065(30)(26)(49)(10)(30)584249
Net income to common shareholders––(30)(26)(83)(16)(37)–––
MIMEDX GROUP, INC. (MDXG) financial statements · FinancialMD